Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huarong Xiong

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
VASA. Zeitschrift Fur Gefasskrankheiten|September 2, 2025
Predictive factors and models for major adverse cardiovascular and limb events in patients with peripheral arterial diseasePan Song, Huarong Xiong, Xiaoyan Quan, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 26, 2016
Nanocapsule assemblies as effective enzyme delivery systems against hyperuricemiaHuarong Xiong, Yunli Zhou, Qixin Zhou, et al.
Scientific Reports|January 30, 2016
Uricase alkaline enzymosomes with enhanced stabilities and anti-hyperuricemia effects induced by favorable microenvironmental changesYunli Zhou, Mi Zhang, Dan He, et al.
Scientific Reports|July 1, 2017
Erratum: Uricase alkaline enzymosomes with enhanced stabilities and anti-hyperuricemia effects induced by favorable microenvironmental changesYunli Zhou, Mi Zhang, Dan He, et al.
Scientific Reports|July 22, 2025
Diagnosis models to predict peripheral arterial disease: a systematic review and meta analysisXiaoyan Quan, Huarong Xiong, Xiaoyu Liu, et al.
AAPS Pharmscitech|March 29, 2012
Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailabilityQunyou Tan, Shan Liu, Xueliang Chen, et al.
Current Reviews in Clinical and Experimental Pharmacology|July 3, 2020
Comparative Pharmacokinetic Study of Hesperetin after Oral Administration in Normal and Hyperuricemia Rats by UPLC-MS/MSKexin Li, Li Wei, Zhigang Han, et al.
Patient Related Outcome Measures|December 27, 2024
Development and Validation of the Self-Management Questionnaire for Patients with Lower Extremity Arterial Disease Who Underwent Endovascular RevascularizationMeihong Shi, Xi Yang, Pan Song, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|November 8, 2024
Risk-Prediction Model of Restenosis after Endovascular Treatment for Peripheral Arterial Disease: A Systematic Review and Meta-analysisXiaoyan Quan, Yang Liu, Huarong Xiong, et al.
ACS Applied Materials & Interfaces|September 2, 2015
Nanosomal Microassemblies for Highly Efficient and Safe Delivery of Therapeutic EnzymesHuarong Xiong, Yunli Zhou, Qixin Zhou, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
VASA. Zeitschrift Fur Gefasskrankheiten|September 2, 2025
Predictive factors and models for major adverse cardiovascular and limb events in patients with peripheral arterial diseasePan Song, Huarong Xiong, Xiaoyan Quan, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 26, 2016
Nanocapsule assemblies as effective enzyme delivery systems against hyperuricemiaHuarong Xiong, Yunli Zhou, Qixin Zhou, et al.
Scientific Reports|January 30, 2016
Uricase alkaline enzymosomes with enhanced stabilities and anti-hyperuricemia effects induced by favorable microenvironmental changesYunli Zhou, Mi Zhang, Dan He, et al.
Scientific Reports|July 1, 2017
Erratum: Uricase alkaline enzymosomes with enhanced stabilities and anti-hyperuricemia effects induced by favorable microenvironmental changesYunli Zhou, Mi Zhang, Dan He, et al.
Scientific Reports|July 22, 2025
Diagnosis models to predict peripheral arterial disease: a systematic review and meta analysisXiaoyan Quan, Huarong Xiong, Xiaoyu Liu, et al.
AAPS Pharmscitech|March 29, 2012
Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailabilityQunyou Tan, Shan Liu, Xueliang Chen, et al.
Current Reviews in Clinical and Experimental Pharmacology|July 3, 2020
Comparative Pharmacokinetic Study of Hesperetin after Oral Administration in Normal and Hyperuricemia Rats by UPLC-MS/MSKexin Li, Li Wei, Zhigang Han, et al.
Patient Related Outcome Measures|December 27, 2024
Development and Validation of the Self-Management Questionnaire for Patients with Lower Extremity Arterial Disease Who Underwent Endovascular RevascularizationMeihong Shi, Xi Yang, Pan Song, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|November 8, 2024
Risk-Prediction Model of Restenosis after Endovascular Treatment for Peripheral Arterial Disease: A Systematic Review and Meta-analysisXiaoyan Quan, Yang Liu, Huarong Xiong, et al.
ACS Applied Materials & Interfaces|September 2, 2015
Nanosomal Microassemblies for Highly Efficient and Safe Delivery of Therapeutic EnzymesHuarong Xiong, Yunli Zhou, Qixin Zhou, et al.
Pageof 2